Piper Jaffray & Co. maintains a 'Buy' on Anadys Pharmaceuticals (Nasdaq: ANDS), Adds stock to the Alpha List.

Piper ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE